Chronic injury of human renal microvessels with low-dose cyclosporine therapy

Area of Science:

• Nephrology
• Transplantation Immunology
• Pharmacology

Background:

• Cyclosporine (CsA) is a crucial immunosuppressant in organ transplantation.
• Understanding CsA's long-term renal effects is vital for patient outcomes.

Purpose of the Study:

• To investigate the physiological and morphological impact of low-dose versus high-dose CsA on kidney function in cardiac transplant recipients.
• To evaluate the dose-dependent effects of CsA on renal hemodynamics and microvasculature.

Main Methods:

• Physiological and morphological assessments of kidney function.
• Measurement of glomerular filtration rate (GFR) and renal vascular resistance.
• Analysis of arteriolopathy, glomerular changes, and pressure gradients.
• Fractional dextran clearances and isoporous membrane modeling to assess transglomerular pressure.

Main Results:

• Both low- and high-dose CsA were associated with azotemia, hypertension, depressed GFR, and elevated renal vascular resistance after 12 months.
• Morphological analysis revealed obliterative arteriolopathy and glomerular sclerosis in CsA-treated groups.
• CsA therapy induced an increasing pressure gradient between renal artery and peritubular capillaries, indicating microvascular compromise.
• Transglomerular hydraulic pressure difference was reduced by CsA, suggesting impaired glomerular filtration dynamics.

Conclusions:

• Chronic CsA therapy leads to afferent arteriole constriction and occlusion, causing irreversible downstream glomerular damage.
• The dose of CsA (low vs. high) provides only marginal protection against CsA-induced microvascular injury.
• These findings highlight the nephrotoxic potential of CsA, necessitating careful monitoring and potential therapeutic adjustments.